Back to search
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Medium-chain Acyl-CoA Dehydrogenase Deficiency trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Medium-chain Acyl-CoA Dehydrogenase Deficiency trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a medical research study to test a medication in patients 4 years of age and older with a disease called medium-chain acyl-CoA dehydrogenase deficiency…
The aim of this project is to investigate the physiological effects of intake of long-chain fatty acids (LCFA) and medium-chain fatty acids (MCFA) in patients w…
Ammonia is a waste product of protein and amino acid catabolism and is also a potent neurotoxin. High blood ammonia levels on the brain can manifest as cytotoxi…
Expanded access may be provided for qualified patients who have limited treatment options and are not eligible for a clinical trial.
The objective of this study is to conduct a longitudinal, observational investigation to determine the natural history of Multiple Acyl-CoA Dehydrogenase Defici…
The main goal of this study is to evaluate the effects of triheptanoin versus Medium-chain Triglycerides (MCT) on frequency of Major Clinical Events (MCEs).